Tirzepatide helped people with the disease who were overweight or had obesity lose up to 16% of their body weight over nearly 17 months, officials with Eli Lilly and Co. said.
Original article: https://www.reviewjournal.com/life/health/type-2-diabetes-drug-could-revolutionize-weight-loss-care-2768643/
